Literature DB >> 31025830

Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites.

Sachie Yamada1, Midori Hasegawa2, Norio Nii1, Masao Kato1, Atsushi Ohashi3, Ryota Suzuki4, Masakazu Komatsu4, Kosei Abe5, Yosuke Hata5, Kazuo Takahashi2, Hiroki Hayashi2, Shigehisa Koide2, Naotake Tsuboi2, Daijo Inaguma2, Yukio Yuzawa2.   

Abstract

Cell-free and concentrated ascites reinfusion therapy (CART) by internal filtration pressure method (internal method) and external filtration pressure method (external method) using the same cancerous ascites was performed. The rate of rise in circuit pressure and recovered components were compared between the two methods. The factors related to circuit pressure rise were also researched. In both methods, circuit pressure rose in 50% of cases. The recovery rates of IgG, IgA, IgM, and haptoglobin were significantly higher for the internal method than for the external method, whereas the recovery rate of α1 -antitrypsin was significantly lower in the internal method than in the external method. The levels of IL-6, haptoglobin, α1 -antitrypsin, and fibrinogen/fibrindegradation products (FDP) in the original ascites were significantly higher in the group wherein circuit pressure rose than in that without circuit pressure rise. These proteins might be related to the rise in circuit pressure.
© 2019 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Ascites; Cancer; Filtration; Proteins; Therapy

Year:  2019        PMID: 31025830     DOI: 10.1111/1744-9987.12821

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites.

Authors:  Kenichi Koga; Takeshi Ishihara; Yohei Doi; Ryota Suzuki; Masakazu Komatsu; Kosei Abe; Takahiro Tanaka; Ryuji Iwaki; Hiroyuki Hashi; Akira Sugawara
Journal:  Ther Apher Dial       Date:  2021-10-28       Impact factor: 2.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.